Affordable Access

Access to the full text

The Prolonged Use of VV ECMO Support in COVID-19: A Case Report

Authors
  • Fitzgerald, Amelia Lucy1
  • Vachharajani, Hemal Hitesh1
  • Davidson, Benjamin Paul1
  • Kruit, Natalie Joanne1
  • Eslick, Adam Trevor1, 2
  • 1 Westmead Hospital, Westmead, Australia , (Australia)
  • 2 Faculty of Medicine, University of Sydney, Australia , (Australia)
Type
Published Article
Journal
The Journal of Critical Care Medicine
Publisher
Sciendo
Publication Date
Nov 07, 2020
Volume
6
Issue
4
Pages
224–230
Identifiers
DOI: 10.2478/jccm-2020-0034
Source
De Gruyter
Keywords
License
Green

Abstract

COVID-19 has resulted in unprecedented global health and economic challenges. The reported mortality in patients with COVID-19 requiring mechanical ventilation is high. VV ECMO may serve as a lifesaving rescue therapy for a minority of patients with COVID-19; however, its impact on overall survival of these patients is unknown. To date, few reports describe successful discharge from ECMO in COVID-19 after a prolonged ECMO run. The only Australian case of a COVID-19 patient, supported by prolonged VV ECMO in conjunction with prone ventilation, complicated by significant airway bleeding, and successfully decannulated after forty-two days, is described. VV ECMO is a resource-intense form of respiratory support. Providing complex therapies such as VV ECMO during a pandemic has its unique challenges. This case report provides a unique insight into the potential clinical sequelae of COVID-19, supported in an intensive care environment which was not resource-limited at the time, and adds to the evolving experience of prolonged VV ECMO support for ARDS with a goal to lung recovery.

Report this publication

Statistics

Seen <100 times